Related Experiment Videos
Prognostic implications of cytogenetic aberrations in diffuse large B-cell lymphomas
M Jerkeman1, B Johansson, M Akerman
1Department of Oncology, University Hospital, Lund, Sweden. mats.jerkeman@onk.lu.se
European Journal of Haematology
|March 25, 1999
Summary
This study found no independent prognostic value for specific chromosomal abnormalities in diffuse large B-cell lymphoma (DLBL) patients treated with chemotherapy. Karyotypic patterns did not significantly predict survival outcomes in DLBL.
Area of Science:
- Hematology
- Oncology
- Cytogenetics
Background:
- Diffuse large B-cell lymphoma (DLBL) is an aggressive non-Hodgkin lymphoma.
- Treatment often involves anthracycline-based chemotherapy.
- The prognostic significance of specific chromosomal aberrations in DLBL remains under investigation.
Purpose of the Study:
- To retrospectively investigate the correlation between specific cytogenetic abnormalities and patient survival in DLBL.
- To determine if karyotypic patterns have independent prognostic value in DLBL.
Main Methods:
- Retrospective analysis of 81 DLBL patients treated at a single institution.
- Cytogenetic analysis of clonal chromosome changes.
- Univariate and multivariate analyses to assess the prognostic impact of various chromosomal aberrations.
Main Results:
- Clonal chromosome changes were present in 79 of 81 cases.
- Univariate analysis suggested shorter survival associated with 1q21-23 breakpoints and trisomy 6.
- Multivariate analysis, adjusted for clinical factors, revealed no independent prognostic value for the tested cytogenetic aberrations.
Conclusions:
- The study found no evidence to support the prognostic importance of the investigated chromosomal abnormalities in DLBL.
- Clinical factors like age, stage, performance status, and LDH levels remain crucial for DLBL prognosis.